Does Lacosamide Affect Other Drugs?
Lacosamide, an antiepileptic drug sold as Vimpat, has minimal impact on other drugs. It does not significantly inhibit or induce major cytochrome P450 (CYP) enzymes, including CYP1A2, 2B6, 2C9, 2C19, or 3A4, so it rarely alters the metabolism or blood levels of co-administered medications.[1][2]
Key Drug Interactions Caused by Lacosamide
- Limited CYP effects: No clinically relevant changes in exposure to drugs like carbamazepine, gabapentin, lamotrigine, levetiracetam, metformin, omeprazole, or warfarin when taken with lacosamide.[1]
- Oral contraceptives: Lacosamide does not reduce effectiveness of ethinylestradiol or levonorgestrel.[1][2]
- CNS depressants: Additive effects with alcohol, benzodiazepines, or opioids, increasing dizziness, somnolence, and ataxia risk.[2]
- Drugs with sodium channel effects: Potential additive cardiac risks (e.g., PR interval prolongation) with beta-blockers, calcium channel blockers, or other sodium channel blockers like carbamazepine.[1][2]
Mechanisms Behind Low Interaction Risk
Lacosamide primarily binds to slow-inactivated sodium channels and works via CRMP-2 binding, bypassing CYP pathways. It is metabolized mainly by CYP2C19 (minor role) and excreted renally, with low protein binding (15%). This profile limits pharmacokinetic interactions.[1][2]
How Common Are These Interactions?
Interactions are uncommon; lacosamide is labeled low-risk for drug-drug interactions in epilepsy polytherapy. Clinical trials showed no significant changes in AUC or Cmax for most tested drugs.[1]
Compared to Other Antiepileptics
Unlike enzyme-inducing drugs (e.g., carbamazepine, phenytoin, which lower levels of oral contraceptives or warfarin), lacosamide avoids these issues. It resembles levetiracetam or topiramate (non-inducers) but has even fewer reported interactions.[2]
Drugs That Affect Lacosamide Instead
Strong CYP2C19 inducers (e.g., rifampin) may slightly reduce lacosamide levels (AUC drop ~15%), but no dose adjustment needed. No major inhibitors affect it.[1][2]
Clinical Advice for Patients
Monitor for additive sedation with CNS drugs. ECG if combining sodium channel agents in cardiac patients. No routine adjustments for most combos.[2]
[1]: FDA Vimpat Label
[2]: Drugs.com Lacosamide Interactions